Zebra-Sphinx: Modeling Sphingolipidoses in Zebrafish
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24054747 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Luca Mignani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Experimental Oncology and Immunology and Zebrafish Facility, Department of Molecular and Translational Medicine, University of Brescia, 25123…. Hauptthemen laut MEDLINE: Sphingolipidoses, Lysosomal Storage Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research, Associazione Italiana per la Ricerca sul Cancro, AIRC fellowship.
Abstract (Originalsprache)
Sphingolipidoses are inborn errors of metabolism due to the pathogenic mutation of genes that encode for lysosomal enzymes, transporters, or enzyme cofactors that participate in the sphingolipid catabolism. They represent a subgroup of lysosomal storage diseases characterized by the gradual lysosomal accumulation of the substrate(s) of the defective proteins. The clinical presentation of patients affected by sphingolipid storage disorders ranges from a mild progression for some juvenile- or adult-onset forms to severe/fatal infantile forms. Despite significant therapeutic achievements, novel strategies are required at basic, clinical, and translational levels to improve patient outcomes. On these bases, the development of in vivo models is crucial for a better understanding of the pathogenesis of sphingolipidoses and for the development of efficacious therapeutic strategies. The teleost zebrafish (Danio rerio) has emerged as a useful platform to model several human genetic diseases owing to the high grade of genome conservation between human and zebrafish, combined with precise genome editing and the ease of manipulation. In addition, lipidomic studies have allowed the identification in zebrafish of all of the main classes of lipids present in mammals, supporting the possibility to model diseases of the lipidic metabolism in this animal species with the advantage of using mammalian lipid databases for data processing. This review highlights the use of zebrafish as an innovative model system to gain novel insights into the pathogenesis of sphingolipidoses, with possible implications for the identification of more efficacious therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Experimental Oncology and Immunology and Zebrafish Facility, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.
ORCID-Profile: Luca Mignani, Davide Capoferri, Marco Presta
Förderung
- Italian Association for Cancer Research
- Associazione Italiana per la Ricerca sul Cancro
- AIRC fellowship
Zitieren
APA
Mignani, L., Guerra, J., Corli, M., Capoferri, D., & Presta, M. (2023). Zebra-Sphinx: Modeling Sphingolipidoses in Zebrafish. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24054747
Vancouver
Mignani L, Guerra J, Corli M, Capoferri D, Presta M. Zebra-Sphinx: Modeling Sphingolipidoses in Zebrafish. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24054747
BibTeX
@article{Mignani2023,
author = {Mignani, Luca and Guerra, Jessica and Corli, Marzia and Capoferri, Davide and Presta, Marco},
title = {Zebra-Sphinx: Modeling Sphingolipidoses in Zebrafish},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24054747}
}
EUVIMED